Real-world healthcare costs of relapsed/refractory multiple myeloma during the era of novel cancer agents

Research output: Contribution to journalArticleAcademicpeer-review

36 Citations (Scopus)
Original languageEnglish
Pages (from-to)41-47
Number of pages7
JournalJournal of Clinical Pharmacy and Therapeutics
Volume38
DOIs
Publication statusPublished - 2013

Research programs

  • EMC NIHES-05-63-02 Quality

Cite this